You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Novo Nordisk acquires Akero Therapeutics for USD 4,7 billion
Text:
Kim Liedholm | [email protected]
Just one month after Novo Nordisk's major restructuring to sharpen its focus on its core areas, a major investment in metabolic liver diseases is now announced. American Akero Therapeutics is acquired for 4,7 billion...